Oleoylethanolamide drug
Evidence from:
primary |
all sources
Related entities (9)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| FAAH | regulates | Oleoylethanolamide | — | 1 |
| Oleoylethanolamide | interacts_with | basolateral amygdala | — | 1 |
| Oleoylethanolamide | associated_with | dopamine release | — | 1 |
| Oleoylethanolamide | associated_with | FAAH | — | 1 |
| Oleoylethanolamide | associated_with | memory | — | 1 |
| Oleoylethanolamide | interacts_with | PPARA | — | 1 |
| Oleoylethanolamide | targets | PPARα | — | 1 |
| Oleoylethanolamide | protective_against | Reinforcing properties of nicotine | — | 1 |
| URB597 | regulates | Oleoylethanolamide | — | 1 |
Mentioned in (4)
Papers in which this entity is mentioned.
- Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans. (2015)
- Endocannabinoids are conserved inhibitors of the Hedgehog pathway. (2015)
- Cannabinoid receptor 1 signaling in embryo neurodevelopment. (2012)
- Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors. (2011)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| oleoylethanolamide | drug | 3 | 6 |
| oea | drug | 2 | 5 |